Journal of Clinical Endocrinology & Metabolism, Vol 74, 543-547, Copyright © 1992 by Endocrine Society
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth
JW Koper, R Markstein, C Kohler, DJ Kwekkeboom, CJ Avezaat, SW Lamberts and JC Reubi
Department of Medicine, Erasmus University Rotterdam, The Netherlands.
It has been reported previously that most human meningiomas have receptors
for somatostatin. Here we report the results of investigations of the
effect of somatostatin and the somatostatin analog octreotide on the growth
in vitro of human meningioma cells. Neither somatostatin nor its analog
showed a direct growth inhibitory action on cultured human meningioma
cells. Rather, there was a slight but significant stimulation of growth in
the presence of somatostatin. The somatostatin receptors in meningioma
tissue were shown to be functional since somatostatin inhibited
forskolin-stimulated formation of cAMP by meningioma membranes. In
addition, cAMP inhibited the growth of cultured meningioma cells. We
conclude that the stimulation by somatostatin of the growth of human
meningioma cells in vitro is caused by its inhibitory effect on cAMP
formation. These results suggest that therapeutic trials of patients with
(recurrent) inoperable meningiomas with somatostatin analogs have to be
carried out with great caution.